227 related articles for article (PubMed ID: 22071509)
1. Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5.
Harbison CE; Weichert WS; Gurda BL; Chiorini JA; Agbandje-McKenna M; Parrish CR
J Gen Virol; 2012 Feb; 93(Pt 2):347-355. PubMed ID: 22071509
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity.
Tseng YS; Gurda BL; Chipman P; McKenna R; Afione S; Chiorini JA; Muzyczka N; Olson NH; Baker TS; Kleinschmidt J; Agbandje-McKenna M
J Virol; 2015 Feb; 89(3):1794-808. PubMed ID: 25410874
[TBL] [Abstract][Full Text] [Related]
3. Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.
Emmanuel SN; Smith JK; Hsi J; Tseng YS; Kaplan M; Mietzsch M; Chipman P; Asokan A; McKenna R; Agbandje-McKenna M
J Virol; 2022 Feb; 96(3):e0125121. PubMed ID: 34757842
[TBL] [Abstract][Full Text] [Related]
4. Capsid antibodies to different adeno-associated virus serotypes bind common regions.
Gurda BL; DiMattia MA; Miller EB; Bennett A; McKenna R; Weichert WS; Nelson CD; Chen WJ; Muzyczka N; Olson NH; Sinkovits RS; Chiorini JA; Zolotutkhin S; Kozyreva OG; Samulski RJ; Baker TS; Parrish CR; Agbandje-McKenna M
J Virol; 2013 Aug; 87(16):9111-24. PubMed ID: 23760240
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.
Tseng YS; Vliet KV; Rao L; McKenna R; Byrne BJ; Asokan A; Agbandje-McKenna M
J Virol Methods; 2016 Oct; 236():105-110. PubMed ID: 27424005
[TBL] [Abstract][Full Text] [Related]
6. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection.
Wobus CE; Hügle-Dörr B; Girod A; Petersen G; Hallek M; Kleinschmidt JA
J Virol; 2000 Oct; 74(19):9281-93. PubMed ID: 10982375
[TBL] [Abstract][Full Text] [Related]
8. High-Resolution Structural Characterization of a New Adeno-associated Virus Serotype 5 Antibody Epitope toward Engineering Antibody-Resistant Recombinant Gene Delivery Vectors.
Jose A; Mietzsch M; Smith JK; Kurian J; Chipman P; McKenna R; Chiorini J; Agbandje-McKenna M
J Virol; 2019 Jan; 93(1):. PubMed ID: 30333169
[TBL] [Abstract][Full Text] [Related]
9. Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion.
Tse LV; Klinc KA; Madigan VJ; Castellanos Rivera RM; Wells LF; Havlik LP; Smith JK; Agbandje-McKenna M; Asokan A
Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4812-E4821. PubMed ID: 28559317
[TBL] [Abstract][Full Text] [Related]
10. Age-Related Seroprevalence of Antibodies Against AAV-LK03 in a UK Population Cohort.
Perocheau DP; Cunningham S; Lee J; Antinao Diaz J; Waddington SN; Gilmour K; Eaglestone S; Lisowski L; Thrasher AJ; Alexander IE; Gissen P; Baruteau J
Hum Gene Ther; 2019 Jan; 30(1):79-87. PubMed ID: 30027761
[TBL] [Abstract][Full Text] [Related]
11. [The preparation of monoclonal antibodies against AAV2 and study on their characterizations].
Tan SP; Yuan ZH; Tian WH; Dong XY; Wu XB
Bing Du Xue Bao; 2009 Jul; 25(4):267-73. PubMed ID: 19769159
[TBL] [Abstract][Full Text] [Related]
12. Structural Study of Aavrh.10 Receptor and Antibody Interactions.
Mietzsch M; Yu JC; Hsi J; Chipman P; Broecker F; Fuming Z; Linhardt RJ; Seeberger PH; Heilbronn R; McKenna R; Agbandje-McKenna M
J Virol; 2021 Nov; 95(23):e0124921. PubMed ID: 34549984
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models.
Rapti K; Louis-Jeune V; Kohlbrenner E; Ishikawa K; Ladage D; Zolotukhin S; Hajjar RJ; Weber T
Mol Ther; 2012 Jan; 20(1):73-83. PubMed ID: 21915102
[TBL] [Abstract][Full Text] [Related]
15. Development of AAV serotype-specific ELISAs using novel monoclonal antibodies.
Kuck D; Kern A; Kleinschmidt JA
J Virol Methods; 2007 Mar; 140(1-2):17-24. PubMed ID: 17126418
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).
Cabral TM; Berhane Y; Schmidt L; Tracz DM; Hole K; Leith M; Corbett CR
J Virol Methods; 2012 Jul; 183(1):25-33. PubMed ID: 22575685
[TBL] [Abstract][Full Text] [Related]
17. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
[TBL] [Abstract][Full Text] [Related]
18. Modifiers of Adeno-Associated Virus-Mediated Gene Expression in Implication for Serotype-Universal Neutralizing Antibody Assay.
Krotova K; Aslanidi G
Hum Gene Ther; 2020 Oct; 31(19-20):1124-1131. PubMed ID: 32495655
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.
Li C; Narkbunnam N; Samulski RJ; Asokan A; Hu G; Jacobson LJ; Manco-Johnson MJ; Monahan PE;
Gene Ther; 2012 Mar; 19(3):288-94. PubMed ID: 21697954
[TBL] [Abstract][Full Text] [Related]
20. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.
Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV
Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
